TB CAB’s proposed development pathway for regimens to treat XDR-TB
1147  

TB CAB’s proposed development pathway for regimens to treat XDR-TB

One of the most critical scientific questions in TB today is the optimal combination of new and repurposed drugs for the treatment of extensively drug-resistant, pre- extensively drug-resistant, and hard-to-treat multidrug-resistant TB (XDR-TB, pre-XDR-TB, MDR-TB). Тhe Global TB Community Advisory Board (TB CAB) has developed a ...

August 18, 2017
News